INNO-LiPA® HPV Genotyping Extra II
Line probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV).
- Individual identification of 32 genotypes.
- One genotype = one probe line.
- Ready-to-use mastermix.
- Automation.
- Primer mix for RT-PCR application.
- Cervical cells, first-void urine and formalin-fixed paraffin-embedded tissue (CE).
Product number 81534
Product number 81533
Click here to navigate
- Contact sales for information
- Details
- Conditions of sale
- Citations
- Documentation
- Insights
- Product inquiry
- Related products
-
Details
Features and benefitsFull genotyping
- Simultaneous detection of 32 HPV genotypes.
- SPF10 Plus provides high test sensitivity due to the precision of the short 65-base pair PCR product, even in case of degraded DNA (FFPE samples), low viral load and mixed HPV infection.1,2,3
- SPF10 Plus permits simultaneous detection of multiple genotypes in a single sample.
Built-in controls
- Special HPV control lines to confirm and detect the presence of a broad range of mucosal HPV genotypes plus additional controls to monitor sample processing (hDNA line, conjugate control line).
Streamlining
- Easy and ready-to-use master mix, with Taq DNA polymerase provided for minimum manipulation steps and hands-on time.
CE Applications:
- Cervical cells collected in Surepath medium or PreservCyt medium.
- First-void urine with preservative.
- Formalin-fixed paraffin embedded (FFPE) material.
RUO Applications:
- HPV Primer Mix SPF10 Plus for Real-Time PCR application.
Automation
- Auto-LiPA™ 48: up to 48 tests per run from sample incubation to color development.
- AutoBlot 3000H: up to 20 tests per run from sample incubation to color development.
- TENDIGO®: up to 10 tests per run from sample incubation to color development.
- Results within +/- 3 hours.
- Minimum hands-on time, accurate results.
- Interpretation software for complete traceability.
References- Xu L. et al. Clinical Evaluation of INNO-LiPA HPV Genotyping Extra II Assay Using the VALGENT Framework. Int J Mol Sci. 2018; 19(9), 2704
- Ahmadi S. et al. Human Papilloma Virus Genotype Distribution in Cervical lesions in Zanjan, Iran. Asian Pac J Cancer Prev. 2017; 18(12):3373-3377
- Sohrabi et al. Is incidence of multiple HPV genotypes rising in genital infections? J Infect Public Health. 2017; 10(6):730-733
-
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
-
Citations
-
Documentation
Browse regulatory documents for this product
Create a (free!) eServices account and start browsing all product documentation right away.
Get access to this section and more
Create a free eServices account now and instantly access multiple digital resources:
- Product documentation
- Selected scientific posters
- Product leaflets
- How-to videos and more…
-
Insights
May 3, 2024EUROGIN 2024 – key takeaway messages
The annual EUROGIN conference covers a dense scientific program on the topic of Human papillomavirus (HPV) and its associated cancers, always with a...
May 2, 2024Scientific poster – Inter- and intra-laboratory reproducibility of the AmpFire® HPV Screening 16/18/HR assay
This poster summarizes the investigation of the reproducibility (within a laboratory and between laboratories) of the AmpFire HPV Screening 16/18/HR...
Nov 6, 2023A risk-based approach for post-treatment detection of recurrent CIN
This article describes how HPV genotyping and DNA methylation analysis can help discriminate women in need of re-treatment from those who can be...
-
Product inquiry
-
Related products